Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...

Leading institutional investors commit $240 million through private investment in public equity (PIPE) led by Perceptive Advisors and RA Capital - - Freenome stockholders ...

Leading institutional investors commit $240 million through private investment in public equity (PIPE) led by Perceptive Advisors and RA Capital – – Freenome stockholders, PCSC shareholders and PIPE ...

As new technology capable of detecting dozens of early-stage cancer types with a single blood test hits the market, support ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...

The Columbus Regional Health Lung Institute has been named a Center of Excellence by GO2 for Lung Cancer (GO2) for its ...

New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

Mercy BioAnalytics, a company dedicated to reducing suffering and saving lives through the early detection of cancer, today announced the appointment of Ellen Snow as its Chief Financial Officer. Snow ...

Criscilla Anderson has died after a seven-year colon cancer battle. She announced her death in a posthumous post, and her ...

ACS--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced that Chief Medical Officer ...